Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Semaglutide vs White Willow Bark: Semaglutide has the stronger overall evidence (8.5 vs 6/10); the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Semaglutide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Likely helps
4 of 4 studies with measurable effects showed benefit.
Top outcomes
Prescription-only, clinician-titrated. Subcutaneous (Wegovy weight management: escalate to 2.4 mg once weekly; Ozempic diabetes: 0.5-2.0 mg once weekly). Oral (Rybelsus diabetes: 3-14 mg once daily). DO NOT self-dose.
any
Subcutaneous once-weekly injection (Ozempic / Wegovy)
120-240mg salicin daily (from standardized extract)
With meals, Divided doses
Standardized extract (15% salicin)
Weeks to months
Months (titrated over 16-20 weeks)
Months to years
Especially during dose escalation
1-2 weeks
1-4 weeks
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).
N Engl J Med (2021) · Rct · n=1961
Double-blind RCT in 1,961 adults with obesity/overweight WITHOUT diabetes, randomized 2:1 to subcutaneous semaglutide 2.4 mg/week or placebo plus lifestyle for 68 weeks
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT).
N Engl J Med (2023) · Rct · n=17604
Large cardiovascular-outcomes RCT: 17,604 patients with preexisting cardiovascular disease and overweight/obesity but WITHOUT diabetes
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6).
N Engl J Med (2016) · Rct · n=3297
Pre-approval cardiovascular-safety RCT in 3,297 patients with type 2 diabetes at high cardiovascular risk, semaglutide (0.5/1.0 mg/week) vs placebo for 104 weeks
Efficacy and Safety of White Willow Bark (Salix alba) Extracts
Phytotherapy research : PTR (2015) · Review
In recent years, various in vitro and animal studies have demonstrated that the anti-inflammatory activity of willow bark extract is associated with down regulation of the inflammatory mediators tumor necrosis factor-α and nuclear factor-kappa B.
A systematic review on the effectiveness of willow bark for musculoskeletal pain
Phytotherapy research : PTR (2009) · Systematic review
All studies investigated ethanolic extracts with daily doses up to 240 mg salicin over periods of up to six weeks.
The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential
Cell proliferation (2006) · Review
For several millennia, the willow tree and salicin have been associated with salicylic acid, the key precursor molecule that has contributed to the discovery of acetylsalicylic acid, traded as aspirin.
Based on Cochrane review showing dose-response relationship with 240mg more effective than 120mg. Studies limited to 6 weeks duration. Requires salicin-standardized extract.
AI-estimated from published studies. Interpret as directional guidance.
Semaglutide has a higher evidence score (8.5/10 vs 6/10) and wins in 2 of 3 categories.
No known interactions between Semaglutide and White Willow Bark have been documented in our database. However, always consult a healthcare provider before combining supplements.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.